Piracétam : Risque hémorragique = Piracetam: hemorrhage riskLa Revue Prescrire. 2005, Vol 25, Num 257, issn 0247-7750, p. 23Article

New methods for determination of cinnarizine in mixture with piracetam by spectrodensitometry, spectrophotometry, and liquid chromatographyMETWALLY, Fadia H; ELZEANY, B. A; DARWISH, H. W et al.Journal of AOAC International. 2005, Vol 88, Num 6, pp 1666-1676, issn 1060-3271, 11 p.Article

Simultaneous Determination of Piracetam and Vincamine by Spectrophotometric and High-Performance Liquid Chromatographic MethodsSHAKER, Yasser; EL-SAHARTY, Ibrahim.Journal of AOAC International. 2008, Vol 91, Num 2, pp 311-321, issn 1060-3271, 11 p.Article

Effect of Position Isomerism on the Formation and Physicochemical Properties of Pharmaceutical Co-CrystalsXIANGMIN LIAO; GAUTAM, Mohan; GRILL, Andreas et al.Journal of pharmaceutical sciences. 2010, Vol 99, Num 1, pp 246-254, issn 0022-3549, 9 p.Article

Advances in Pharmaceutical Co-crystal Screening: Effective Cocrystal Screening through Structural ResemblanceSPRINGUEL, Géraldine; NORBERG, Bernadette; ROBEYNS, Koen et al.Crystal growth & design. 2012, Vol 12, Num 1, pp 475-484, issn 1528-7483, 10 p.Article

The effect of piracetam on ataxia : clinical observations in a group of autosomal dominant cerebellar ataxia patientsGUNAL, D. Ince; AGAN, K; AFSAR, N et al.Journal of clinical pharmacy and therapeutics (Print). 2008, Vol 33, Num 2, pp 175-178, issn 0269-4727, 4 p.Article

Piracetam and levetiracetam : close structural similarities but different pharmacological and clinical profilesGENTON, P; VAN VLEYMENT, B.Epileptic disorders. 2000, Vol 2, Num 2, pp 99-105, issn 1294-9361Article

ETUDE CLINIQUE CONCERNANT LE PIRACETAMMARTIN C; SOBOTKA F; CHAZOT G et al.1973; LYON MED.; FR.; DA. 1973; VOL. 229; NO 5; PP. 525-527Serial Issue

Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spellsSAWIRES, Happy; BOTROUS, Osama.European journal of pediatrics. 2012, Vol 171, Num 7, pp 1063-1067, issn 0340-6199, 5 p.Article

Effect of Systemic Piracetam Treatment on Flap Survival and Vascular Endothelial Growth Factor Expression after Ischemia-Reperfusion InjuryTUNCER, Serhan; AYHAN, Suhan; FINDIKCIOGLU, Kemal et al.Journal of reconstructive microsurgery. 2011, Vol 27, Num 7, pp 409-417, issn 0743-684X, 9 p.Article

Synthesis of valproic acid amides of a melatonin derivative, a piracetam and amantadine for biological testsCHATTERJIE, Nithiananda; ALEXANDER, George; HSIN WANG et al.Neurochemical research. 2001, Vol 26, Num 10, pp 1171-1176, issn 0364-3190Article

Antimyoclonic efficacy of piracetam in idiopathic generalized epilepsyKHANI, Yahya Agha; ANDERMANN, Frederick; ANDERMANN, Eva et al.Epilepsia (Copenhagen). 2005, Vol 46, Num 7, pp 1145-1146, issn 0013-9580, 2 p.Article

A study of crystalline forms of piracetamPAVLOVA, A; KONSTANTINOVA, K; DASKALOV, H et al.Pharmazie. 1983, Vol 38, Num 9, issn 0031-7144, 634Article

Suppression of myoclonus in SCA2 by piracetamDE ROSA, Anna; STRIANO, Pasquale; BARBIERI, Fabrizio et al.Movement disorders. 2006, Vol 21, Num 1, pp 116-118, issn 0885-3185, 3 p.Article

A comparative study of the use of powder X-ray diffraction, Raman and near infrared spectroscopy for quantification of binary polymorphic mixtures of piracetamCROKER, Denise M; HENNIGAN, Michelle C; MAHER, Anthony et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 63, pp 80-86, issn 0731-7085, 7 p.Article

HPLC determination of piracetam in tablets; Validation of the methodARDHANI DWI LESTARI; PRASETYO, Andi Tri; PALUPI, Tini et al.Journal of liquid chromatography & related technologies. 2005, Vol 28, Num 9, pp 1407-1416, issn 1082-6076, 10 p.Article

Separation of piracetam derivatives on polysaccharide-based chiral stationary phasesKAZOKA, H; KOLISKINA, O; VEINBERG, G et al.Journal of chromatography. 2013, Vol 1281, pp 160-165, issn 0021-9673, 6 p.Article

Piracetam for acute ischemic strokeRICCI, Stefano; GRAZIA CELANI, Maria; CANTISANI, Teresa Anna et al.Stroke (1970). 2006, Vol 37, Num 8, pp 2191-2192, issn 0039-2499, 2 p.Article

2-Pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugsSCAPECCHI, Serena; MARTELLI, Cecilia; GHELARDINI, Carla et al.Il Farmaco (Pavia). 2003, Vol 58, Num 9, pp 715-722, issn 0014-827X, 8 p.Article

Clinical efficacy of piracetam in cognitive impairment: A meta-analysisWAEGEMANS, Tony; WILSHER, Colin R; DANNIAU, Anne et al.Dementia and geriatric cognitive disorders. 2002, Vol 13, Num 4, pp 217-224, issn 1420-8008Article

The effectiveness of piracetam in vertigoOOSTERVELD, W. J.Pharmacopsychiatry. Supplement. 1999, Vol 32, Num 1, pp 54-59, issn 0936-9589Article

Intérêt du Nootropyl^R dans le traitement des acouphènes. Etude en double aveugle randomisée, Piracétam versus placebo = Importance of Nootropyl in the treatment of tinnitus.Double blind randomised study,Piracetam versus placeboLEGENT, F.Les Cahiers d'oto-rhino-laryngologie, de chirurgie cervico-faciale et d'audiophonologie. 1996, Vol 31, Num 7, pp 435-441, issn 0395-3971Article

THE EFFECT OF PIRACETAM (NOOTROPIL, UCB-6215) UPON THE LATE SYMPTOMS OF PATIENTS WITH HEAD INJURIES.AANTAA F; MEURMAN OH.1975; J. INTERNATION. MED. RES.; G.B.; DA. 1975; VOL. 3; NO 5; PP. 352-355; BIBL. 7 REF.Article

Examining Solution and Solid State Composition for the Solution-Mediated Polymorphic Transformation of Carbamazepine and PiracetamO'MAHONY, Marcus A; MAHER, Anthony; CROKER, Denise M et al.Crystal growth & design. 2012, Vol 12, Num 4, pp 1925-1932, issn 1528-7483, 8 p.Article

Investigation of the Solid-State Polymorphic Transformations of PiracetamMAHER, Anthony; SEATON, Colin C; HUDSON, Sarah et al.Crystal growth & design. 2012, Vol 12, Num 12, pp 6223-6233, issn 1528-7483, 11 p.Article